Author(s): Neha T. Nistane, Vishal R. Gajbhiye

Email(s): nehanistane8@gmail.com , vish2891@gmail.com

DOI: 10.52711/0975-4377.2024.00031   

Address: Neha T. Nistane1, Vishal R. Gajbhiye2
1Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Maharashtra 441002, India.
2S.K.B College of Pharmacy, Gada, Kamptee, Maharashtra 441002, India.
*Corresponding Author

Published In:   Volume - 16,      Issue - 2,     Year - 2024


ABSTRACT:
The global burden of cancer disease is steadily increasing, and because of the symptoms of chemotherapy, there is a great deal of interest in herbal treatment. Herbal products appear to be innocuous and at that time they can meddle with malignancy treatment. An enormous volume of clinical examinations has detailed that the helpful impacts of natural herbal products on the endurance, insusceptible regulation, and Quality of life (QOL) of malignant growth patients. Herbal drugs can deflect chemotherapy from executing malignancy cells certain herbal products improve the impact of chemotherapy. Nanoparticles of herbal drugs are used to target the drug in a specific site which results better efficacy and better bioavailability than any other formulations. The investigation of nanoparticles on herbal drugs to treat cancer, for example. Sesquiterpenoid from Tussilagofarfara, oligopeptides from Perillafrutescens, Oxymatrine from Sophora Flavescens, Curcumin from curcuma longa, vincristine from Catharanthusroseus, Berberine from Berberis vulgaris, Quercetin from Cuscutachinensis, Paclitaxel from Taxusbrevifolia, Camptothein from camptotheca acuminate, Catechins from camellia sinesis etc. In summary, this review emphasizes how important herbal nanoparticles are to boosting the effectiveness of cancer treatment. Through clarifying the limitations of chemotherapy and highlighting the advantages of novel herbal nanoparticle formulations, this study adds to the current conversation on complementary and alternative methods to cancer treatment.


Cite this article:
Neha T. Nistane, Vishal R. Gajbhiye. Nanoparticles of Various Herbal Drugs Extract Produce Anticancer Activity: Review. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(2):194-2. doi: 10.52711/0975-4377.2024.00031

Cite(Electronic):
Neha T. Nistane, Vishal R. Gajbhiye. Nanoparticles of Various Herbal Drugs Extract Produce Anticancer Activity: Review. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(2):194-2. doi: 10.52711/0975-4377.2024.00031   Available on: https://rjpdft.com/AbstractView.aspx?PID=2024-16-2-12


REFERENCE:
1.    Wiart C. Etnopharmacology of medicinal plants. New Jersey: Humana Press; 2006. pp. 1–50.
2.    L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-tieulent, A. Jemal, Global Cancer statistics, 2012, CA a Cancer J. Clin. 65 (2015) 87–108, https://doi.org/10. 3322/caac.21262.
3.    L.A. Torre, R.L. Siegel, E.M. Ward, A. Jemal, Global Cancer Incidence and Mortality Rates and Trends–An Update, Cancer Epidemiol. Biomarkers Prev. 25 (2016) 16–27, https://doi.org/10.1158/1055-9965.EPI-15-0578.
4.    J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, F. Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer 136 (2015) E359–E386, https://doi.org/10.1002/ijc.29210.
5.    Singh SS, Venire H, Singh B., Nanotechnologybased drug delivery systems, J Occup Med Toxicol. 2007; 2: 16.
6.    Gerber B, Müller H, Reimer T, Krause A, Friese K. Nutrition and lifestyle factors on the risk of developing breast cancer. Breast Cancer Research and Treatment. 2003; 79(2):265–276.
7.    Sivaraj R, Rahman PKSM, Rajiv P, Vanathi P, Venckatesh R. Biosynthesis and characterization of Acalypha indica mediated copper oxide nanoparticles and evaluation of its antimicrobial and anticancer activity. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2014; 129: 255–258.
8.    Balantrapu K, Goia DV (2009) Silver nanoparticles for printable electronics and biological applications. J Mat Res 24(09): 2828–2836
9.    Hasan KMF, Pervez MN, Talukder ME, Sultana MZ, Mahmud S, Meraz MM, Bansal V, Genyang C (2019) A novel coloration of polyester fabric through green silver nanoparticles (G-AgNPs@PET). Nanomaterials 9:569
10.    Burdusel AC, Gherasim O, Grumezescu AM, Mogoanta L, Ficai A, Andronescu E (2019) Biomedical applications of silver nanoparticles: an up-to-date overview. Mol 24:719
11.    Tabassum khan, Pranav gurav (2017) Phytonanotechnology: Enhancing delivery of plant based anticancer drug.
12.    Gong P, Li H, He X, Wang K, Hu J, Tan W, Tan S, Zhang XY., Preparation and antibacterial activity of Fe3O4 at Ag nanoparticles., Nanotech., 2007; 18: 604–611.
13.    Mahendra R, Yadav A, Gade A., Biotech Adv., 2009; 27(1): 76-83.
14.    Rai M, Yadav A, Gade A., Biotech Adv., 2009; 27(2): 813-817.
15.    Sharma VK, Ria AY, Lin Y., Adv Colloid and Interface Sci., 2009; 145: 83-96.
16.    Bar H, Bhui DK, Sahoo GP, Sarkar P, De SP, Misra A., Colloids and Surfaces., Physicochem. Eng. Aspects., 2009; 339: 134-139.
17.    Shankar SS, Rai A, Ankamwar B, Singh A, Ahmad A, Sastry., Biological synthesis of triangular gold nanoprisms., Nat Mater., 2004; 3: 482-488.
18.    Jha AK, Prasad K., Green Synthesis of Silver Nanoparticles Using Cycas Leaf. Int J Green Nanotech: Physics and Chemistry., 2010; 1: 110-117.
19.    Baban D, Seymour LW., Control of tumour vascular permeability., Adv Drug Delivery Rev., 1998; 34: 109-119.
20.    Tomar A, Garg G., Short Review on Application of Gold Nanoparticles, Global Journal of Pharmacology. 2013; 7 (1): 34-38.
21.    Fan TX, Chow SK, Zhang D., Biomorphic mineralization: from biology to materials, Progress in Materials Sci. 2009; 54(5): 542- 659.
22.    Kou WK, Kaohsiung KW. Water Soluble Extract from Plant of Solanum Genus and the Preparation Process Thereof, and Pharmaceutical Composition Containing the Water soluble Extract. US Patent 20040247715 A1, 9 December 2004.
23.    Kou WK, Kaohsiung KW. Water Soluble Extract from Plant of Solanum Genus and the Preparation ProcessThereof, and Pharmaceutical Composition Containing the Water Soluble Extract. EP Patent 1508334 B1, 23 February 2006.
24.    Kou WK, Kaohsiung KW. Water Soluble Extract from Plant of Solanum Genus and the Preparation Process Thereof, and Pharmaceutical Composition Containing the Water Soluble Extract. US Patent 007078063 B2, 18 July 2006.
25.    Gorur A, Shanmugasundaram S, Shanmugasundaram S. Preparation of agar bio nanoparticles. IP Patent 376MAS200 3A, 6 January 2007.
26.    Shanmugasundaram S, Krupakar P, Shanmugasundaram S. Preparation of oligosaccharide bio nanoparticles from moringa oleifera lam. IP Patent 375MAS2003 A, 6 August 2007.
27.    Danek. Combination anti-cancer therapy. WIPO Patent WO/2013/ 066864 10 May 2013.
28.    Einbond L, Redenti S. Growth inhibitory effects of nanoparticles containing triterpene glycosides or triterpenes. US Patent 2013/0177657 A1, 11 July 2013.
29.    Patel AR, Tiwari JK, Velikov KP, Particles comprising hydrophobic polymer and hydrophobic phenolic compound. WO Patent 2012000757 A1, 5 January 2012.
30.    Rigas B, Mackenzie G, Yu S, Huang L, Zhu, R, Nie T. Combination treatment and formulation for cancer. WO patent 201130486 A2, 20 October 2011.s
31.    You Jeong Lee, Kwangho Song, Song-Hyun Cha, Seonho Cho, Yeong Shik Kim and Youmie Park Sesquiterpenoids from Tussilago farfara Flower Bud Extract for the Eco-Friendly Synthesis of Silver and Gold Nanoparticles Possessing Antibacterial and Anticancer Activities. Nanomaterials 2019, 9, 819; doi: 10.3390/nano9060819.
32.    NV Reddy, Huizhen Li, Tianyu Hou, MS Bethu, Zhiqing Ren, Zhijun Zhang. Photosynthesis of Silver Nanoparticles Using Perilla frutescens Leaf Extract: Characterization and Evaluation of Antibacterial, Antioxidant, and Anticancer Activities. International Journal of Nano medicine 2021:16.
33.    Mukherjee A, Vishwanathan JK. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res 2009; 29: 3867-75.
34.    Cheng Jin, Ling Bai, Hong Wu, Junye Liu, Guozhen Guo and Jingyuan Chen. Paclitaxel-loaded poly (D, L-lactide-co-glycolide) nanoparticles for radiotherapy in hypoxic human tumor cells in vitro. Cancer Biology and Therapy 2008; Vol. 7 Issue 6.
35.    Lin AH, Li HY, Liu YM. Preparation and release characteristics of berberine chitosan nanoparticles in vitro. China Pharm 2007; 18: 755- 7.
36.    Chen Y, Lin X, Park H, Greever R. Study of artemisinin nanocapsules as anticancer drug delivery systems Nanomedicine: Nanotechnology. BioMed 2009; 5: 316-22

37.    Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, et al. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 2008; 127: 208-18.
38.    H.L. Li, G.X. Zhai, W.W. Zhu, L.B. Li, Y.K. Ma, Studies on quercetin solid lipid nanoparticles and oral absorption in mice, China Pharmacy Journal 43 (2008) 435–438
39.    Yang CS, Wang X: Green tea and cancer prevention. 2010; 62: 931–937
40.    Yoonho Choi, Myung-Jin Choi, Song-Hyun Cha, Yeong Shik Kim, Seonho Cho and Youmie Park. Catechin-capped gold nanoparticles: green synthesis, characterization, and catalytic activity toward 4-nitrophenol reduction. Nanoscale Research Letters 2014; 9: 103 http://www.nanoscalereslett.com/content/ 9/1/103.
41.    Yen FL, Wu TH, Lin LT, Cham TM, Lin CC. Nanoparticle’s formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats. Food Chem Toxicol 2008; 46: 1771-1777.
42.    Labouebe ZM, Lange N, Gurny R, Delie F. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int J Pharm 2006; 326: 174-181
43.    Hua-yang Fan, Zhuo-li Zhu1, Hong-chun Xian, Hao-fan Wang, Bing-jun Chen, Ya-Jie Tang, Ya-ling Tang and Xin-hua Liang. Insight into the Molecular Mechanism of Podophyllotoxin Derivatives as Anticancer Drugs.ront. Cell Dev. Biol., 10 August 2021 https://doi.org/10.3389/fcell.2021.709075
44.    A. Abirami, Dr. S. Mohamed Halith, K.K. Pillai, Chithirra anbalagan. Herbal nanoparticle for anticancer potential- A. World Journal of Pharmacy and Pharmaceutical Sciences Vol 3, Issue 8, 2014.
45.    Ana Luiza Chaves Maia and, Carolina de Aguiar Ferreira et.al. Vincristine-loaded hydroxyapatite nanoparticles as a potential delivery system for bone cancer therapy. Journal of Drug Targeting, DOI: 10.1080/1061186X.2017.1401078
46.    R. Siegel, D. Naishadham, A. Jemal, Cancer statistics, CA Cancer J. Clin. 63 (2013) 11–30, https://doi.org/10.3322/caac.21166.
47.    L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-tieulent, A. Jemal, Global Cancer statistics, 2012, CA a Cancer J. Clin. 65 (2015) 87–108, https://doi.org/10. 3322/caac.21262.
48.    L.A. Torre, R.L. Siegel, E.M. Ward, A. Jemal, Global Cancer Incidence and Mortality Rates and Trends–An Update, Cancer Epidemiol. Biomarkers Prev. 25 (2016) 16–27, https://doi.org/ 10.1158/1055-9965.EPI-15-0578.
49.    B.W. Stewart, C.P. Wild, World Cancer Report, World Heal. Organ. 2014, pp. 1–2 doi: 9283204298.
50.    World Health Organisation, WHO Cancer Factsheet, WHO. (2017). doi:/entity/ mediacentre/factsheets/fs297/en/index.html.
51.    J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, F. Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer 136 (2015) E359–E386, https://doi.org/10.1002/ijc.29210.
52.    Canham L, Shabir QU, Loni A. Porous materials. US Patent 20110236493 A1, 29 September 2011.
53.    Jankovic J. Parkinson’s disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008; 79: 368-76.
54.    Dauer W, Przedborski S. Parkinson’s disease: Mechanisms and models. Neuron 2003; 39: 889-909
55.    Ceravolo R, Frosini D, Rossi C, Bonuccelli U. Impulse control disorders in Parkinson’s disease: Definition, epidemiology, risk factors, neurobiology and management. Parkinsonism Relate Disord 2009;15 Supple 4: S111-5.
56.    Jodi N. Chloroquine derivatives for the treatment of Parkinson’s disease. US Patent 6417177 B1, 9 July 2002.
57.    Nair AK, Parthasarathy K, Gokaraju GR, Bhuphatiraju K, Somushekara N, Nanappan R, et al. Curcumoids and its metabolites for the application in allergic ocular/nasal conditions. US Patent 2012/0010297 A1, 12 January 2012.
58.    Nair AK, Parthasarathy K, Gokaraju GR, Bhuphatiraju K, Somushekara N, Nanappan R, et al. Curcumoids and its metabolites for the applicationin allergic ocular/nasal conditions. WO Patent 2010/109482 A2, 30 September 2010.
59.    Kar SK, Akhtar F, Ray G, Pandey AK. Curcumin nanoparticles and methods of producing the same. US Patent 20110190399 A1, 4 August 2011.
60.    Nair AK, Chaniyilparampu RN, Bhupathiraju K, Gokaraju RR, Gokaraju GR, Golakoti T. Process for nanoemulsification of curcumin and derivatives of curcumin. US Patent 20110229532 A1, 22 September 2011.
61.    Xu X, Yu J, Tong S, Zhu Y, Cao X. Formulation of silymarin with high efficacy and prolonged action and the preparation method thereof. US Patent 20110201680 A1, 18 August 2011.
62.    Jacob CV. Synergistic composition for enhancing bioavaliability of curcumin. US Patent 20120058208 A1, 8 March 2012.
63.    Payne AJ, Kurien BT, Scofield RH. Solubilization of curcuminoid compounds and products thereof. WO Patent 2013078477 A2, 30 May 2013.
64.    Tengler M, Taskey P, Lockhart D, McMahen R. Composition and methods of making sustained release liquid formulations. US Patent 20130084340, 4 April 2013.
65.    Wertz CF, Ryde NP. Nanoparticulate compositions having lysozyme as a surface stabilizer. US Patent 007459283 B2, 2 December 2008.
66.    Hu Z, Che Y. Production of organic compound nanoparticles with high repetition rate ultrafast pulsed laser ablation in liquid. US Patent 20110196044 A1, 11 August 2011.
67.    Priem F, Jacquemond-Collet I. Pharmaceutical composition presenting anti-inflammatory and anti-histaminic properties. EP Patent 2229940 A1, 22 September 2010.
68.    Priem F, Jacquemond-Collet I. Pharmaceutical composition presenting anti-inflammatory and anti-histaminic properties. WO Patent 2010106191 A1, 23 September 2010.
69.    Karnik R, Gu FX, Cannizzaro C, Khademhosseini A, Langer RS, Farokhzad OC. Microfludic synthesis of organic nanoparticles. US patent 20100022680 A1, 28 January 2010.
70.    Saba Hasan. A Review on Nanoparticles: Their Synthesis and Types. Research Journal of Recent Sciences. 2015; 4(ISC-2014):  1-3.

Recomonded Articles:

Author(s): Swapnil T. Deshpande, P. S. Vishwe, Rohit D. Shah, Swati S. Korabu, Bhakti R. Chorghe, DG Baheti

DOI:         Access: Open Access Read More

Author(s): Dipti G. Phadtare, Amol R. Pawar, R.B. Saudagar, Govind K.Patil

DOI: 10.5958/0975-4377.2017.00002.7         Access: Open Access Read More

Author(s): Chirag A. Patel, Priyal R. Patel, Dhrubo Jyoti Sen,Jayvadan K. Patel

DOI:         Access: Open Access Read More

Author(s): Kritika Kanoujia, Chandraprabha Dewangan, Ayushi Masih, Dipti Sinha, Divya Oraon, Manisha Jaiswal, Monika Sahu, Ranjeeta Kumari, Sapna Pradhan, Ravi Suman, Rajkishan Dewangan, Roman Banjare, Pradeep Paikra, Mukesh Rawtiya, Mukta Agrawal, Ajazuddin, D. K. Tripathi, Amit Alexander

DOI: 10.5958/0975-4377.2018.00015.0         Access: Open Access Read More

Author(s): Patil Namrata D., Gondkar S.B., Saudagar R.B.

DOI: 10.5958/0975-4377.2016.00033.1         Access: Open Access Read More

Author(s): Hardik B. Rana, Kajol Patel, Mansi Dholakia, Vaishali T. Thakkar, Mukesh C. Gohel, Tejal R. Gandhi

DOI: 10.5958/0975-4377.2017.00006.4         Access: Open Access Read More

Author(s): Ashok Thulluru, K. Saravanakumar, Ch. S. Phani Kumar, Nawaz Mahammed, D. Sreeja, G. Bhuvanesh, N. Vamsi Chowdary, Nayeema Khowser Shaik

DOI: 10.5958/0975-4377.2019.00049.1         Access: Open Access Read More

Author(s): Varsha R. Sandhan, S.B. Gondkar, R. B. Saudagar

DOI:         Access: Open Access Read More

Author(s): Suresh A. Marnoor

DOI:         Access: Open Access Read More

Author(s): Masheer Ahmed Khan

DOI:         Access: Open Access Read More

Author(s): Shoaib Ahmad

DOI: 10.5958/0975-4377.2016.00041.0         Access: Open Access Read More

Author(s): V. Saikishore, G. Srikanth, Ch. Pooja, Y. Mrudula, R. Pavani, Ch. Jyosthna , C. Mayuren

DOI:         Access: Open Access Read More

Author(s): Patel Chirag J., Asija Sangeeta, Patel Pinkesh, Mangukia Dhruv, Satyanand Tyagi

DOI:         Access: Open Access Read More

Author(s): Swati Rawat, Shradha Sangali, Akhilesh Gupta

DOI: 10.5958/0975-4377.2018.00001.0         Access: Open Access Read More

Author(s): Nakkala Balaji , V. Sai Kishore , Kasani Hari Krishna Gouda

DOI:         Access: Open Access Read More

Author(s): Abhijit Chormale, Dharmendra Mundhada, Rajesh Mujoriya

DOI: 10.5958/0975-4377.2015.00026.9         Access: Open Access Read More

Author(s): Samadhan K. Deore, Rajendra K Surawase, Avish Maru

DOI: 10.5958/0975-4377.2019.00045.4         Access: Open Access Read More

Research Journal of Pharmaceutical Dosage Forms and Technology (RJPDFT) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. ...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/0975-4377 


Recent Articles




Tags